A massive outbreak of Chikungunya occurred in Bangladesh during the period of AprilSeptember, 2017 and over two million people were at risk of getting infected by the virus. A prospective cohort of viremic patients was constituted and analyzed to define the clinical, hematological and long-term aspects of this outbreak. A 35-day long comprehensive survey was conducted in two major, neighboring cities, Dhaka and Mymensingh. One-hundred and eighty-seven clinically proven Chikungunya cases were enrolled in the cross-sectional cohort study. Additionally, a smaller group of 48 Chikungunya patients was monitored for postinfection effects for 12 months. Clinical data revealed that a combination of fever and arthralgia (oligoarthralgia and/or polyarthralgia) was the cardinal hallmark (97.9% of cases) of the infection. Hematological analysis showed that, irrespective of age groups, hemoglobin level significantly decreased and erythrocyte sedimentation rate remarkably increased in Chikungunya confirmed patients. However, the majority of the patients had a normal range of whole WBC and platelet counts; RBC counts for mid aged (40 -60 years) and senior (61+ years) patients (especially in the females) were beyond the reference values. The post-infection study revealed that children had an early recovery from the infection compared to the adults.
5
Clinical and hematological manifestation of Chikungunya 25 clade, suggesting that they are novel variants [29] . Together with variability in symptoms, 83% 26 of patients in Dhaka also had low to very low overall quality of life, and ~30% patients had 27 ambulatory problems due to severe arthropathy [30] . However, the impact of ChikV on 28 hematological parameters and its long-term effects have not yet been studied. In this study, 29 hematological parameters were assessed during the Chikungunya 2017 outbreaks in a cohort 30 of 187 patients; a subgroup of these was continuously followed afterwards to better understand 31 the long-term effects.
32

Materials and Methods
Patient recruitment, sample collection and data analysis
34
During the period of June 30, 2017 to August 4, 2017, 187 clinically confirmed, RT-35 PCR or serological test positive patients from Dhaka and Mymensingh were recruited 36 randomly in this study (Fig 1) . A cross-sectional study was done to investigate the clinical, 37 biochemical and hematological profiling, and a long-term follow-up was conducted to 38 understand the after effect of Chikungunya on the quality of life. Only clinically proven 39 Chikungunya patients were included; patients with respiratory and cardiovascular symptoms, 40 previous report of arthralgia, any kind of arthritis, rheumatism, any major recent injuries or 41 blood disorders were excluded from the study. Patients with proven evidence of previous or 42 present infection by Dengue virus were also not included in the study. Among the 187 enrolled 43 patients, 48 were found willing to follow a long-term monitoring scheme of 12 months (Long 44 term consequence assessment group; LCA) (Fig 1) . 51 Sero-biochemical and long-term effect study
52
Biochemical and serological test results were collected after they were prescribed and 53 performed by a specialist physician and a specialist diagnostic center respectively. Relative 54 intensity of joint pain was evaluated using a numerical rating (NR) scale starting from 0 to 10.
55 A rating of 0 indicated that the individual had no joint pain, and a rating of 10 indicates 56 intolerable joint pain. Using these relative scores given by the patients, the pain intensity was 57 categorized as mild (NR 1 -4), moderate (NR 5 -7) and severe (8 -10). The anatomical 58 location(s) of the pain and how long it existed after ChikV infection were also documented. (Fig 2) . Also, 32 children (≤15 yrs) were included in this study. 
94
Arthralgia was observed at 12 different anatomical sites (Fig 3) , with hand joints 95 (fingers and wrist), leg joints (ankle, knee and feet), and shoulder and neck joints being most 96 often affected in the Chikungunya patients. Importantly, arthralgia was typically symmetrical.
97 The intensity of the pain was stronger when patients tried to move. None of the patients 98 reported arthralgia specific to a single anatomical site. Other signs and symptoms which were 99 less frequent included gastrointestinal (GI) and respiratory (RD) complaints.
10
Clinical and hematological manifestation of Chikungunya
Fig 3: Sites of pain due to Chikungunya infection
101
The signs and symptoms pattern of Chikungunya seemed remarkably different in 102 children compared to adults (Table 4) . Arthralgia was less present while vomiting was more 103 frequently reported in children. In addition, the frequency of skin rash was notably higher.
104 118 However, at the onset of the disease, no significant correlation was observed between 119 the level of leukocytopenia and the intensity of arthralgic pain. Red blood cell (RBC) count 120 was remarkably above the reference range in the mid aged and senior groups. The interquartile 121 range of the RBC was between 3.2 to 6.22 M/μL and the median value was 4.5 M/μL.
122 Erythrocyte sedimentation rate (ESR) was significantly higher in all age groups, especially in 123 female patients (Table 5) . Further, a significant correlation was obtained between the different 124 age groups and RBC counts, neutrophil counts and leucocyte counts of the ChikV positive 125 patients (S3 Table) . 145 (Fig 5) . When ChikV-induced arthralgia relapsed, it was symmetrical, involving more than 2 146 different anatomical locations. Most frequently, the finger joints, wrists and ankles were 147 affected; regardless of age and sex, some patients complained of pain at elbow joint and knee.
Fig 4: Scatter diagram of hematological findings of ChikV positive patients. Shadowed area
denotes the reference ranges. a) Haemoglobin level in females. b) Haemoglobin levels in 128 males. c) RBC counts in females. d) RBC counts in males. e) WBC counts in females. f) WBC 129 counts in males. g) Platelet counts in females. h) Platelet counts in males
148 157 Furthermore, between M6 and M12, 16.67% (n = 8) complained that they frequently suffered 158 tachycardia during working, even though none of them had any previous heart complications.
159
The number of patients who visited a physician increased significantly between M6 (4; 160 8.33%) and M12 (16; 33%, data not shown) (p < 0.005). However, the most significant after-161 effect of the infection in our study population appeared to be post infection weakness. Around 162 40% of the patients reported to have continuous weakness at M2. The percentage decreased 163 significantly at M6, increasing however again to ~17% at M9 and M12. Besides, more than 164 20% of patients complained about sleep disorder at M2 and M4, but the percentage diminished 165 to less than 10% at M6. However, complaints of disturbed sleep slightly increased at M9 and 166 M12 (Fig 5) .
167
Over 10% of patients complained of new symptoms at M2 which they had not suffered 168 from during the acute phase of the infection (Fig 5) . Even at M6, 6.25% patients reported to 169 suffer new symptoms and more than 4% patients to experience new symptoms at M9. However, 170 we did not attempt to find any association between the newly gained symptoms and the effect 171 of the RNA virus infection. Although the new symptoms were generally sleeping problems, 172 swelling of joints, arthritis-like symptoms and memory problems were also reported. Although 173 the respondents did not display any neurological dysfunction, the mild memory problems could 174 not be excluded to result from the ChikV infection. Some of the patients reported that they 175 were frequently prone to depression and partially lost control over their temper.
Post infection impact on daily life at M6 and M12
177 Arthralgia coupled with weakness in patients at M6 and M12 were highly incapacitating 178 for daily life activities, professional life and leisure activities (Table 6) . Most of the patients 179 having chronic arthralgia complained of pain when rising from sitting and lying, walking or 180 picking up a load. Twenty-seven percent and ~23% patients respectively in M6 and M12
181 reported that the arthralgia affected their professional activities. Remarkably, ~31% patients 182 complained that arthralgia had disturbed them in leisure. Moreover, all the patients having 183 memory problems complained that it had significant impact on their day to day life activities.
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